Volume 54, Issue 4, Pages (October 1998)

Slides:

Advertisements

Similar presentations

Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis Giuseppe D’Amico Kidney International Volume 54, Issue 2, Pages

Advertisements

An alcoholic patient with recurrent renal failure and proteinuria T. Kumagai, Y. Hori, G. Seki, Toshiro Fujita Kidney International Volume 70, Issue 8,

Volume 54, Issue 4, Pages (October 1998)

Melamine toxicity: one more culprit in calcium kidney lithiasis

Michael D. Gautreaux, Barry I. Freedman Kidney International

Propofol-related green urine

Recalcitrant pain in a patient with ADPKD

Volume 83, Issue 3, Pages (March 2013)

Lipopheresis in the nephrotic syndrome

Stem cells for kidney repair: useful tool for acute renal failure?

ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target Szu-Chun Hung, Der-Cherng Tarng Kidney International

Continuous renal replacement therapy in the critically ill patient

Volume 135, Issue 4, Pages (October 2008)

Volume 56, Issue 2, Pages (August 1999)

Francesco Paolo Schena Kidney International

Peripheral microvascular parameters in the nephrotic syndrome

Volume 70, Pages S21-S25 (December 2006)

Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy? Fu L. Luan, Diane E. Steffick,

Comorbidity and confounding in end-stage renal disease

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease S. Bianchi, R. Bigazzi, V.M. Campese

Unfavorable course of minimal change nephrotic syndrome in children with intrauterine growth retardation Nina Zidar, Mojca Avguštin Čavić, Rajko B. Kenda,

Prospective randomized study of individual and group psychotherapy versus controls in recipients of renal transplants1 Lyndsay S. Baines, John T. Joseph,

David Del Bello, Michael J. Ross, Shirish S. Huprikar

Melamine toxicity: one more culprit in calcium kidney lithiasis

Blood pressure targets in hemodialysis patients

Response to ‘Hepcidin levels in patients with renal disease’

Volume 75, Issue 11, Pages (June 2009)

Volume 76, Issue 6, Pages (September 2009)

Volume 87, Issue 1, Pages (January 2015)

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

J.M. van den Akker, J.F.M. Wetzels, A.J. Hoitsma Kidney International

Hepatitis C treatment in patients with kidney disease

Volume 85, Issue 1, Pages 3-4 (January 2014)

Volume 56, Issue 4, Pages (October 1999)

Simvastatin in nephrotic syndrome

Counteracting progression of renal disease: A look into the future

Nephrology Crossword: Glomerulonephritis

Volume 71, Issue 4, Pages (February 2007)

Volume 87, Issue 5, Pages (May 2015)

Mediterranean diets: are they practical in the Western world?

Proteinuria in obstructive sleep apnea

Serum cystatin C-immunoglobulin high-molecular-weight complexes in kidney and liver transplant patients Jesús Hermida, Rafael Romero, J. Carlos Tutor

Long-term survival in renal transplant recipients with graft function

Racial differences in survival of patients on dialysis

Organ transplantation goes to the movies

Volume 54, Issue 4, Pages (October 1998)

Does equal care give equal outcomes?

Stephen P. Mcdonald, Graeme R. Russ Kidney International

Volume 72, Issue 8, Pages (October 2007)

Volume 63, Issue 6, Pages (June 2003)

American Indian heritage and risk factors for renal injury

Is it the low-protein diet or simply the salt restriction?

Charles A. Herzog Kidney International

Is complement a target for therapy in renal disease?

Volume 70, Issue 3, Pages (August 2006)

Volume 70, Issue 5, Pages (September 2006)

The changing face of childhood nephrotic syndrome

Dana V. Rizk, David G. Warnock Kidney International

The international realities of live donor kidney transplantation

The International Pediatric Peritonitis Registry: Starting to walk

Abby S. Kazley, Kit N. Simpson, Kenneth D. Chavin, Prabhakar Baliga

S. Dmitrienko, A. Yu, R. Balshaw, R.J. Shapiro, P.A. Keown

Volume 57, Issue 2, Pages (October 2000)

Prediction in idiopathic membranous nephropathy

Volume 62, Issue 2, Pages (August 2002)

Ronen Levi, Justin Silver Kidney International

Volume 66, Issue 1, Pages (July 2004)

Presentation transcript:

Volume 54, Issue 4, Pages 1311-1319 (October 1998) Effects of ribavirin on hepatitis C-associated nephrotic syndrome in four liver transplant recipients Hung-Patrick Pham, Cyrille Féray, Didier Samuel, Michèle Gigou, Daniel Azoulay, Valérie Paradis, Francis Ducret, Bernard Charpentier, Brigitte Debuire, Antoinette Lemoine Kidney International Volume 54, Issue 4, Pages 1311-1319 (October 1998) DOI: 10.1046/j.1523-1755.1998.00113.x Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 1 Laboratory data on patients #1 (A), #2 (B) #3 (C) and #4 (D) during ribavirin therapy. Symbols are: (▧) albuminemia, g/liter; (•) proteinuria, g/liter; (○) creatininemia, μm/liter. In (B), (C) and (D), proteinuria is expressed as g/24hours. Kidney International 1998 54, 1311-1319DOI: (10.1046/j.1523-1755.1998.00113.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 1 Laboratory data on patients #1 (A), #2 (B) #3 (C) and #4 (D) during ribavirin therapy. Symbols are: (▧) albuminemia, g/liter; (•) proteinuria, g/liter; (○) creatininemia, μm/liter. In (B), (C) and (D), proteinuria is expressed as g/24hours. Kidney International 1998 54, 1311-1319DOI: (10.1046/j.1523-1755.1998.00113.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 1 Laboratory data on patients #1 (A), #2 (B) #3 (C) and #4 (D) during ribavirin therapy. Symbols are: (▧) albuminemia, g/liter; (•) proteinuria, g/liter; (○) creatininemia, μm/liter. In (B), (C) and (D), proteinuria is expressed as g/24hours. Kidney International 1998 54, 1311-1319DOI: (10.1046/j.1523-1755.1998.00113.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 1 Laboratory data on patients #1 (A), #2 (B) #3 (C) and #4 (D) during ribavirin therapy. Symbols are: (▧) albuminemia, g/liter; (•) proteinuria, g/liter; (○) creatininemia, μm/liter. In (B), (C) and (D), proteinuria is expressed as g/24hours. Kidney International 1998 54, 1311-1319DOI: (10.1046/j.1523-1755.1998.00113.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Kidney International 1998 54, 1311-1319DOI: (10. 1046/j. 1523-1755 Kidney International 1998 54, 1311-1319DOI: (10.1046/j.1523-1755.1998.00113.x) Copyright © 1998 International Society of Nephrology Terms and Conditions